Marc Poirier

Discovery of a 3-(4-Pyrimidinyl) Indazole (MLi-2), an Orally Available and Selective Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitor that Reduces Brain Kinase Activity

Jack D. Scott, Duane E. DeMong, Thomas J. Greshock et al. · Journal of Medicinal Chemistry · 2017 · 140 citations · Full text

Drug Target, Pharmacotherapy, Medicinal Chemistry +16

A New Method for the Reduction of Esters

Jacqueline Boyer, Robert J. P. Corriu, R. Perz et al. · Synthesis · 1981 · 55 citations

Chemical Engineering, Derivative (Chemistry), Engineering +5

Novel ZnX₂-ModulatedPd/C and Pt/C Catalysts for Chemoselective Hydrogenationand Hydrogenolysis of Halogen-Substituted Nitroarenes,Alkenes, Benzyl Ethers, and Aromatic Ketones

George G. Wu, Mingsheng Huang, M. Richards et al. · Synthesis · 2003 · 48 citations

Materials Science, Chemical Engineering, Novel Organocatalysts +14

Diverse Catalytic Reactions for the Stereoselective Synthesis of Cyclic Dinucleotide MK-1454

Tamas Benkovics, Feng Peng, Eric M. Phillips et al. · Journal of the American Chemical Society · 2022 · 45 citations

Combinatorial Chemistry, Bioorganic Chemistry, Engineering +20

Novel 2,2-Bipyridine Ligand for Palladium-Catalyzed Regioselective Carbonylation

George G. Wu, Y.-S. Wong, Marc Poirier · Organic Letters · 1999 · 34 citations

Sch 66336, Novel 2,2-Bipyridine Ligand, Formation Aromatic Amides +11